 | • レポートコード：MRC2-11QY06837 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は緑内障治療薬のグローバル市場について調査・分析したレポートです。種類別（経口タイプ、注射タイプ）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別緑内障治療薬の競争状況、市場シェア ・世界の緑内障治療薬市場：種類別市場規模 2015年-2020年（経口タイプ、注射タイプ） ・世界の緑内障治療薬市場：種類別市場規模予測 2021年-2026年（経口タイプ、注射タイプ） ・世界の緑内障治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、在宅ケア） ・世界の緑内障治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、在宅ケア） ・北米の緑内障治療薬市場分析：米国、カナダ ・ヨーロッパの緑内障治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの緑内障治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の緑内障治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの緑内障治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aerie Pharmaceuticals、Akorn Inc.、Alcon、Allergan plc、Bausch & Lomb Incorporated、Inotek Pharmaceuticals、Merck & Co. Inc、Pfizer Inc、Santen Pharmaceutical Co. Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Glaucoma Treatment Drugs Market
The global Glaucoma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Glaucoma Treatment Drugs Scope and Market Size
Glaucoma Treatment Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glaucoma Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Glaucoma Treatment Drugs market is segmented into
Oral Type
Injection Type
Segment by Application, the Glaucoma Treatment Drugs market is segmented into
Hospital
Clinic
Home Care
Regional and Country-level Analysis
The Glaucoma Treatment Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glaucoma Treatment Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glaucoma Treatment Drugs Market Share Analysis
Glaucoma Treatment Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glaucoma Treatment Drugs business, the date to enter into the Glaucoma Treatment Drugs market, Glaucoma Treatment Drugs product introduction, recent developments, etc.
The major vendors covered:
Aerie Pharmaceuticals
Akorn Inc.
Alcon
Allergan plc
Bausch & Lomb Incorporated
Inotek Pharmaceuticals
Merck & Co. Inc
Pfizer Inc
Santen Pharmaceutical Co. Ltd
1 Study Coverage
1.1 Glaucoma Treatment Drugs Product Introduction
1.2 Market Segments
1.3 Key Glaucoma Treatment Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glaucoma Treatment Drugs Market Size Growth Rate by Type
1.4.2 Oral Type
1.4.3 Injection Type
1.5 Market by Application
1.5.1 Global Glaucoma Treatment Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Glaucoma Treatment Drugs Market Size, Estimates and Forecasts
2.1.1 Global Glaucoma Treatment Drugs Revenue 2015-2026
2.1.2 Global Glaucoma Treatment Drugs Sales 2015-2026
2.2 Global Glaucoma Treatment Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Glaucoma Treatment Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Glaucoma Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Glaucoma Treatment Drugs Competitor Landscape by Players
3.1 Glaucoma Treatment Drugs Sales by Manufacturers
3.1.1 Glaucoma Treatment Drugs Sales by Manufacturers (2015-2020)
3.1.2 Glaucoma Treatment Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Glaucoma Treatment Drugs Revenue by Manufacturers
3.2.1 Glaucoma Treatment Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Glaucoma Treatment Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glaucoma Treatment Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glaucoma Treatment Drugs Revenue in 2019
3.2.5 Global Glaucoma Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Glaucoma Treatment Drugs Price by Manufacturers
3.4 Glaucoma Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Glaucoma Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glaucoma Treatment Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Glaucoma Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glaucoma Treatment Drugs Market Size by Type (2015-2020)
4.1.1 Global Glaucoma Treatment Drugs Sales by Type (2015-2020)
4.1.2 Global Glaucoma Treatment Drugs Revenue by Type (2015-2020)
4.1.3 Glaucoma Treatment Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glaucoma Treatment Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Glaucoma Treatment Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Glaucoma Treatment Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Glaucoma Treatment Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glaucoma Treatment Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Glaucoma Treatment Drugs Market Size by Application (2015-2020)
5.1.1 Global Glaucoma Treatment Drugs Sales by Application (2015-2020)
5.1.2 Global Glaucoma Treatment Drugs Revenue by Application (2015-2020)
5.1.3 Glaucoma Treatment Drugs Price by Application (2015-2020)
5.2 Glaucoma Treatment Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Glaucoma Treatment Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Glaucoma Treatment Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Glaucoma Treatment Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Glaucoma Treatment Drugs by Country
6.1.1 North America Glaucoma Treatment Drugs Sales by Country
6.1.2 North America Glaucoma Treatment Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Glaucoma Treatment Drugs Market Facts & Figures by Type
6.3 North America Glaucoma Treatment Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Glaucoma Treatment Drugs by Country
7.1.1 Europe Glaucoma Treatment Drugs Sales by Country
7.1.2 Europe Glaucoma Treatment Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glaucoma Treatment Drugs Market Facts & Figures by Type
7.3 Europe Glaucoma Treatment Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Glaucoma Treatment Drugs by Region
8.1.1 Asia Pacific Glaucoma Treatment Drugs Sales by Region
8.1.2 Asia Pacific Glaucoma Treatment Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Glaucoma Treatment Drugs Market Facts & Figures by Type
8.3 Asia Pacific Glaucoma Treatment Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Glaucoma Treatment Drugs by Country
9.1.1 Latin America Glaucoma Treatment Drugs Sales by Country
9.1.2 Latin America Glaucoma Treatment Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Glaucoma Treatment Drugs Market Facts & Figures by Type
9.3 Central & South America Glaucoma Treatment Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Glaucoma Treatment Drugs by Country
10.1.1 Middle East and Africa Glaucoma Treatment Drugs Sales by Country
10.1.2 Middle East and Africa Glaucoma Treatment Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Glaucoma Treatment Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Glaucoma Treatment Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Aerie Pharmaceuticals
11.1.1 Aerie Pharmaceuticals Corporation Information
11.1.2 Aerie Pharmaceuticals Description and Business Overview
11.1.3 Aerie Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aerie Pharmaceuticals Glaucoma Treatment Drugs Products Offered
11.1.5 Aerie Pharmaceuticals Related Developments
11.2 Akorn Inc.
11.2.1 Akorn Inc. Corporation Information
11.2.2 Akorn Inc. Description and Business Overview
11.2.3 Akorn Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Akorn Inc. Glaucoma Treatment Drugs Products Offered
11.2.5 Akorn Inc. Related Developments
11.3 Alcon
11.3.1 Alcon Corporation Information
11.3.2 Alcon Description and Business Overview
11.3.3 Alcon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Alcon Glaucoma Treatment Drugs Products Offered
11.3.5 Alcon Related Developments
11.4 Allergan plc
11.4.1 Allergan plc Corporation Information
11.4.2 Allergan plc Description and Business Overview
11.4.3 Allergan plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Allergan plc Glaucoma Treatment Drugs Products Offered
11.4.5 Allergan plc Related Developments
11.5 Bausch & Lomb Incorporated
11.5.1 Bausch & Lomb Incorporated Corporation Information
11.5.2 Bausch & Lomb Incorporated Description and Business Overview
11.5.3 Bausch & Lomb Incorporated Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bausch & Lomb Incorporated Glaucoma Treatment Drugs Products Offered
11.5.5 Bausch & Lomb Incorporated Related Developments
11.6 Inotek Pharmaceuticals
11.6.1 Inotek Pharmaceuticals Corporation Information
11.6.2 Inotek Pharmaceuticals Description and Business Overview
11.6.3 Inotek Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Inotek Pharmaceuticals Glaucoma Treatment Drugs Products Offered
11.6.5 Inotek Pharmaceuticals Related Developments
11.7 Merck & Co. Inc
11.7.1 Merck & Co. Inc Corporation Information
11.7.2 Merck & Co. Inc Description and Business Overview
11.7.3 Merck & Co. Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck & Co. Inc Glaucoma Treatment Drugs Products Offered
11.7.5 Merck & Co. Inc Related Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Corporation Information
11.8.2 Pfizer Inc Description and Business Overview
11.8.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Inc Glaucoma Treatment Drugs Products Offered
11.8.5 Pfizer Inc Related Developments
11.9 Santen Pharmaceutical Co. Ltd
11.9.1 Santen Pharmaceutical Co. Ltd Corporation Information
11.9.2 Santen Pharmaceutical Co. Ltd Description and Business Overview
11.9.3 Santen Pharmaceutical Co. Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Products Offered
11.9.5 Santen Pharmaceutical Co. Ltd Related Developments
11.1 Aerie Pharmaceuticals
11.1.1 Aerie Pharmaceuticals Corporation Information
11.1.2 Aerie Pharmaceuticals Description and Business Overview
11.1.3 Aerie Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aerie Pharmaceuticals Glaucoma Treatment Drugs Products Offered
11.1.5 Aerie Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Glaucoma Treatment Drugs Market Estimates and Projections by Region
12.1.1 Global Glaucoma Treatment Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Glaucoma Treatment Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Glaucoma Treatment Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Glaucoma Treatment Drugs Sales Forecast (2021-2026)
12.2.2 North America: Glaucoma Treatment Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Glaucoma Treatment Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Glaucoma Treatment Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Glaucoma Treatment Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Glaucoma Treatment Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Glaucoma Treatment Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Glaucoma Treatment Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Glaucoma Treatment Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Glaucoma Treatment Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Glaucoma Treatment Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Glaucoma Treatment Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Glaucoma Treatment Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Glaucoma Treatment Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Glaucoma Treatment Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Glaucoma Treatment Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Glaucoma Treatment Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Glaucoma Treatment Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Glaucoma Treatment Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Glaucoma Treatment Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glaucoma Treatment Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Glaucoma Treatment Drugs Market Segments
Table 2. Ranking of Global Top Glaucoma Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Glaucoma Treatment Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral Type
Table 5. Major Manufacturers of Injection Type
Table 6. Global Glaucoma Treatment Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Glaucoma Treatment Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Glaucoma Treatment Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Glaucoma Treatment Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Glaucoma Treatment Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Glaucoma Treatment Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Glaucoma Treatment Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Glaucoma Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Glaucoma Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glaucoma Treatment Drugs as of 2019)
Table 15. Glaucoma Treatment Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Glaucoma Treatment Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Glaucoma Treatment Drugs Price (2015-2020) (USD/Unit)
Table 18. Glaucoma Treatment Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Glaucoma Treatment Drugs Product Type
Table 20. Date of International Manufacturers Enter into Glaucoma Treatment Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Glaucoma Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Glaucoma Treatment Drugs Sales Share by Type (2015-2020)
Table 24. Global Glaucoma Treatment Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Glaucoma Treatment Drugs Revenue Share by Type (2015-2020)
Table 26. Glaucoma Treatment Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Glaucoma Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Glaucoma Treatment Drugs Sales Share by Application (2015-2020)
Table 29. North America Glaucoma Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Glaucoma Treatment Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Glaucoma Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Glaucoma Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Glaucoma Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Glaucoma Treatment Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Glaucoma Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Glaucoma Treatment Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Glaucoma Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Glaucoma Treatment Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Glaucoma Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Glaucoma Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Glaucoma Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Glaucoma Treatment Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Glaucoma Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Glaucoma Treatment Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Glaucoma Treatment Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Glaucoma Treatment Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Glaucoma Treatment Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Glaucoma Treatment Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Glaucoma Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Glaucoma Treatment Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Glaucoma Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Glaucoma Treatment Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Glaucoma Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Glaucoma Treatment Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Glaucoma Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Glaucoma Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Glaucoma Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Glaucoma Treatment Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Glaucoma Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Glaucoma Treatment Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Glaucoma Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Glaucoma Treatment Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Glaucoma Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Glaucoma Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Glaucoma Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Glaucoma Treatment Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Glaucoma Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Glaucoma Treatment Drugs Sales Market Share by Application (2015-2020)
Table 69. Aerie Pharmaceuticals Corporation Information
Table 70. Aerie Pharmaceuticals Description and Major Businesses
Table 71. Aerie Pharmaceuticals Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Aerie Pharmaceuticals Product
Table 73. Aerie Pharmaceuticals Recent Development
Table 74. Akorn Inc. Corporation Information
Table 75. Akorn Inc. Description and Major Businesses
Table 76. Akorn Inc. Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Akorn Inc. Product
Table 78. Akorn Inc. Recent Development
Table 79. Alcon Corporation Information
Table 80. Alcon Description and Major Businesses
Table 81. Alcon Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Alcon Product
Table 83. Alcon Recent Development
Table 84. Allergan plc Corporation Information
Table 85. Allergan plc Description and Major Businesses
Table 86. Allergan plc Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Allergan plc Product
Table 88. Allergan plc Recent Development
Table 89. Bausch & Lomb Incorporated Corporation Information
Table 90. Bausch & Lomb Incorporated Description and Major Businesses
Table 91. Bausch & Lomb Incorporated Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Bausch & Lomb Incorporated Product
Table 93. Bausch & Lomb Incorporated Recent Development
Table 94. Inotek Pharmaceuticals Corporation Information
Table 95. Inotek Pharmaceuticals Description and Major Businesses
Table 96. Inotek Pharmaceuticals Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Inotek Pharmaceuticals Product
Table 98. Inotek Pharmaceuticals Recent Development
Table 99. Merck & Co. Inc Corporation Information
Table 100. Merck & Co. Inc Description and Major Businesses
Table 101. Merck & Co. Inc Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Merck & Co. Inc Product
Table 103. Merck & Co. Inc Recent Development
Table 104. Pfizer Inc Corporation Information
Table 105. Pfizer Inc Description and Major Businesses
Table 106. Pfizer Inc Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Pfizer Inc Product
Table 108. Pfizer Inc Recent Development
Table 109. Santen Pharmaceutical Co. Ltd Corporation Information
Table 110. Santen Pharmaceutical Co. Ltd Description and Major Businesses
Table 111. Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Santen Pharmaceutical Co. Ltd Product
Table 113. Santen Pharmaceutical Co. Ltd Recent Development
Table 114. Global Glaucoma Treatment Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 115. Global Glaucoma Treatment Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Glaucoma Treatment Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Glaucoma Treatment Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Glaucoma Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 119. North America: Glaucoma Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Glaucoma Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 121. Europe: Glaucoma Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Glaucoma Treatment Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 123. Asia Pacific: Glaucoma Treatment Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Glaucoma Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 125. Latin America: Glaucoma Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Glaucoma Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 127. Middle East and Africa: Glaucoma Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Glaucoma Treatment Drugs Players
Table 132. Glaucoma Treatment Drugs Customers List
Table 133. Glaucoma Treatment Drugs Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Glaucoma Treatment Drugs Product Picture
Figure 2. Global Glaucoma Treatment Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Type Product Picture
Figure 4. Injection Type Product Picture
Figure 5. Global Glaucoma Treatment Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Home Care
Figure 9. Glaucoma Treatment Drugs Report Years Considered
Figure 10. Global Glaucoma Treatment Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Glaucoma Treatment Drugs Sales 2015-2026 (K Units)
Figure 12. Global Glaucoma Treatment Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Glaucoma Treatment Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Glaucoma Treatment Drugs Sales Market Share by Region in 2019
Figure 15. Global Glaucoma Treatment Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Glaucoma Treatment Drugs Revenue Market Share by Region in 2019
Figure 17. Global Glaucoma Treatment Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Glaucoma Treatment Drugs Revenue in 2019
Figure 19. Glaucoma Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Glaucoma Treatment Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Glaucoma Treatment Drugs Sales Market Share by Type in 2019
Figure 22. Global Glaucoma Treatment Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Glaucoma Treatment Drugs Revenue Market Share by Type in 2019
Figure 24. Global Glaucoma Treatment Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Glaucoma Treatment Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Glaucoma Treatment Drugs Sales Market Share by Application in 2019
Figure 27. Global Glaucoma Treatment Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Glaucoma Treatment Drugs Revenue Market Share by Application in 2019
Figure 29. North America Glaucoma Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Glaucoma Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Glaucoma Treatment Drugs Sales Market Share by Country in 2019
Figure 32. North America Glaucoma Treatment Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Glaucoma Treatment Drugs Market Share by Type in 2019
Figure 38. North America Glaucoma Treatment Drugs Market Share by Application in 2019
Figure 39. Europe Glaucoma Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Glaucoma Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Glaucoma Treatment Drugs Sales Market Share by Country in 2019
Figure 42. Europe Glaucoma Treatment Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Glaucoma Treatment Drugs Market Share by Type in 2019
Figure 54. Europe Glaucoma Treatment Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Glaucoma Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Glaucoma Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Glaucoma Treatment Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Glaucoma Treatment Drugs Revenue Market Share by Region in 2019
Figure 59. China Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Glaucoma Treatment Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Glaucoma Treatment Drugs Market Share by Application in 2019
Figure 83. Latin America Glaucoma Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Glaucoma Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Glaucoma Treatment Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Glaucoma Treatment Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Glaucoma Treatment Drugs Market Share by Type in 2019
Figure 94. Latin America Glaucoma Treatment Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Glaucoma Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Glaucoma Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Glaucoma Treatment Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Glaucoma Treatment Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Glaucoma Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Glaucoma Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Glaucoma Treatment Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Glaucoma Treatment Drugs Market Share by Application in 2019
Figure 107. North America Glaucoma Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Glaucoma Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Glaucoma Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Glaucoma Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Glaucoma Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Glaucoma Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Glaucoma Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Glaucoma Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Glaucoma Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Glaucoma Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…- 緑内障ドレナージ装置の世界市場（～2026年） Market Analysis and Insights: Global Glaucoma Drainage Devices Market The global Glaucoma Drainage Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glaucoma Drainage Devices Scope and Market Size Glaucoma Draina…
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…
- 緑内障医薬品の世界市場（～2026年） Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqu…
- 緑内障の世界市場（～2026年） Glaucoma is an asymptomatic eye-related disorder that occurs due to the buildup of fluid pressure inside the eye. This leads to damage of the optic nerve in the eye, and is a hereditary disorder. Immediate treatment of people suffering from glaucoma is essential as glaucoma in severe cases may resul…